Skip to main content

Site notifications

AusPAR: Sunlenca

Device/Product Name
Sunlenca
Active ingredients
Lenacapavir sodium
AusPAR Date
Published
Submission Number
PM 2022 00982 1 2
Submission Type
New chemical entity
Decision
Approved

Help us improve the Therapeutic Goods Administration site